Holen Sie sich die Stockscreener-App
0.1715
0.15%
0.00035
Schlusskurs vom Vortag:
$0.1711
Offen:
$0.177
24-Stunden-Volumen:
258.94K
Relative Volume:
0.31
Marktkapitalisierung:
$9.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.96M
KGV:
-0.2288
EPS:
-0.7492
Netto-Cashflow:
$-19.63M
1W Leistung:
+3.53%
1M Leistung:
-37.65%
6M Leistung:
-74.89%
1J Leistung:
-87.21%
1-Tages-Spanne:
$0.1672
$0.177
1-Wochen-Bereich:
$0.1603
$0.1868
52-Wochen-Spanne:
$0.1357
$1.50
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Compare ITRM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.1714 | 9.12M | 0 | -26.96M | -19.63M | -0.7492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.70 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.79 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.29 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.82 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.42 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
ITRM Stock Price, Quote & Chart | ITERUM THERAPEUTICS PLC (NASDAQ:ITRM) - ChartMill
Exit Recap: Can Iterum Therapeutics plc sustain its profitability2026 Major Catalysts & Real-Time Volume Triggers - baoquankhu1.vn
Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Lowered by Maxim Group - Defense World
Iterum Therapeutics Appeals Nasdaq Delisting, Explores Strategic Alternatives - The Globe and Mail
Iterum Therapeutics (ITRM) Downgraded Amid Delisting Concerns - GuruFocus
Iterum Therapeutics requests Nasdaq hearing after delisting notice - Investing.com Nigeria
Iterum Therapeutics requests Nasdaq hearing after delisting notice, may face wind-down or strategic sale - TradingView
Iterum Therapeutics (ITRM) faces Nasdaq delisting and flags possible bankruptcy - Stock Titan
Returns Recap: What drives First Majestic Silver Corps stock priceCPI Data & Precise Buy Zone Tips - baoquankhu1.vn
Iterum Therapeutics Faces Nasdaq Delisting, Weighs Strategic Options - TipRanks
Iterum Therapeutics Received Notice of Delisting - TradingView
Nasdaq delisting and wind-down risk at Iterum Therapeutics (NASDAQ: ITRM) - Stock Titan
ITRM Should I Buy - Intellectia AI
ITRM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Smart Money: Does Iterum Therapeutics plc outperform in volatile marketsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - baoquankhu1.vn
What dividend growth rate does Iterum Therapeutics plc offerJuly 2025 Opening Moves & Smart Investment Allocation Tips - mfd.ru
Iterum Therapeutics PLC expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Iterum Therapeutics Shareholders Reject Key Capital Proposals - TipRanks
Iterum Therapeutics (NASDAQ: ITRM) flags going‑concern risk after failed capital votes - Stock Titan
Can Iterum Therapeutics plc sustain its profitabilityEarnings Growth Report & Step-by-Step Trade Execution Guides - mfd.ru
Decliners Report: What dividend growth rate does Iterum Therapeutics plc offer2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH By Investing.com - Investing.com Australia
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH - Investing.com South Africa
Iterum Therapeutics Provides Business Update - Intellectia AI
Iterum Therapeutics Announces Expanded Market Access and Patent Protection for ORLYNVAH™ - Quiver Quantitative
Published on: 2026-02-12 20:05:19 - baoquankhu1.vn
Is Iterum Therapeutics plc’s ROIC above industry averageMarket Weekly Review & Risk Controlled Stock Pick Alerts - mfd.ru
Is Iterum Therapeutics plc stock forming a triangle patternDividend Hike & Low Volatility Stock Recommendations - mfd.ru
Iterum Therapeutics (ITRM) to Release Quarterly Earnings on Friday - Defense World
Investment Review: What dividend growth rate does CTNT offerEarnings Trend Report & Low Risk High Reward Ideas - baoquankhu1.vn
Gap Down: Is UPSD stock a good pick for beginners2025 Key Highlights & Expert Approved Momentum Ideas - baoquankhu1.vn
Fed Meeting: How correlated is W R Berkley Corporation to the S P500July 2025 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
Portfolio Recap: Is Iterum Therapeutics plc stock risky to hold now2025 Earnings Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
Weekly Earnings: How does Hovnanian Enterprises Inc compare to its peersRate Cut & Real-Time Price Movement Reports - baoquankhu1.vn
Activity Recap: What are the future prospects of Iterum Therapeutics plcMarket Sentiment Report & Fast Gaining Stock Reports - baoquankhu1.vn
Patterns Watch: Is Iterum Therapeutics plc stock a safe haven assetLayoff News & Low Risk Entry Point Tips - Bộ Nội Vụ
Will Iterum Therapeutics plc stock benefit from green energy trendsJuly 2025 Earnings & Daily Profit Focused Screening - Улправда
Is Iterum Therapeutics plc stock overvalued by current metricsProfit Target & High Return Trade Opportunity Guides - ulpravda.ru
Will Iterum Therapeutics plc stock benefit from sector rotationInflation Watch & Safe Capital Growth Stock Tips - Улправда
Can Iterum Therapeutics plc stock deliver surprise earnings beatWeekly Trade Report & Expert Curated Trade Setup Alerts - Улправда
Why Iterum Therapeutics plc stock remains a top recommendationStock Buyback Updates & Market Monitoring and Alerts - Улправда
Iterum Therapeutics expands market access for ORLYNVAH antibiotic - Investing.com
Iterum Therapeutics provides business update - marketscreener.com
New antibiotic ORLYNVAH could reach 34M+ people pending FDA feedback - Stock Titan
Analyzing Iterum Therapeutics (NASDAQ:ITRM) & Savara (NASDAQ:SVRA) - Defense World
Why hedge funds are buying Iterum Therapeutics plc stockWeekly Trade Analysis & Capital Efficient Trade Techniques - Улправда
Iterum Therapeutics secures major PBM agreement for antibiotic By Investing.com - Investing.com Nigeria
Iterum Therapeutics (ITRM) Secures Key PBM Agreement and Expands Patent Portfolio - GuruFocus
Iterum Therapeutics secures major PBM agreement for antibiotic - Investing.com
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):